Cutting out the unnecessary: deprescribing antihypertensive treatments in patients at low cardiovascular risk - Scorecard - MDSpire

Cutting out the unnecessary: deprescribing antihypertensive treatments in patients at low cardiovascular risk

  • By

  • Matteo Lemoli

  • Claudia Agabiti Rosei

  • Maria Lorenza Muiesan

  • February 10, 2026

  • 0 min

Share

Clinical Scorecard: Reevaluating Antihypertensive Therapy: Discontinuing Treatment in Patients with Low Cardiovascular Risk

At a Glance

CategoryDetail
ConditionGrade 1 hypertension without target organ damage and low cardiovascular risk
Key MechanismsDiscontinuation of antihypertensive therapy in patients with confirmed low home blood pressure (<135/85 mmHg) and monitoring for normotension maintenance
Target PopulationPatients with uncomplicated Grade 1 hypertension, low cardiovascular risk, treated with monotherapy or low-dose dual therapy
Care SettingPrimary care with general practitioners managing hypertension

Key Highlights

  • 36% of patients maintained normotension at 1 year after antihypertensive treatment withdrawal.
  • Home systolic BP < 122.5 mmHg and diastolic BP < 74.5 mmHg predicted persistence of normotension.
  • Use of angiotensin-receptor blockers (ARBs) was positively associated with normotension maintenance.

Guideline-Based Recommendations

Diagnosis

  • Perform repeated blood pressure measurements to confirm hypertension diagnosis.
  • Use out-of-office blood pressure monitoring for accurate diagnosis except in Grade 3 hypertension or high cardiovascular risk cases.

Management

  • Consider discontinuation of antihypertensive therapy in selected low-risk patients with home BP < 120/80 mmHg.
  • Maintain lifestyle changes and non-pharmacological interventions during and after treatment withdrawal.

Monitoring & Follow-up

  • Schedule periodic blood pressure monitoring at 1, 3, 6, 9, and 12 months after treatment discontinuation.
  • Use home blood pressure monitoring to assess blood pressure control.

Risks

  • Risk of uncontrolled blood pressure requiring treatment restart in 64% of patients within 1 year.
  • Low incidence of adverse cardiovascular events observed during follow-up in selected patients.

Patient & Prescribing Data

Patients with Grade 1 hypertension, low cardiovascular risk, and no target organ damage

Monotherapy or low-dose dual therapy with ARBs may favor normotension maintenance after treatment withdrawal

Clinical Best Practices

  • Confirm hypertension diagnosis with repeated and out-of-office blood pressure measurements before initiating lifelong treatment.
  • Identify patients with home BP < 120/80 mmHg as candidates for safe antihypertensive treatment discontinuation.
  • Ensure regular follow-up and blood pressure monitoring after treatment withdrawal to detect uncontrolled hypertension early.
  • Encourage adherence to lifestyle modifications to support blood pressure control post-treatment.

References

Original Source(s)

Related Content